In the context of GLP-1 medications, microdosing might look like: Remaining at 0.25 mg of semaglutide weekly, rather than titrating to higher maintenance doses Drawing a smaller dose from the pen using an insulin syringe or adjusting based on clicks Taking a low dose biweekly, monthly, or even on an as-needed basis, depending on the individuals goals or tolerance Why Are People Microdosing
Studies have demonstrated bioequivalence between generic and brand-name cyanocobalamin, meaning they have comparable absorption rates and overall effects
Cost and accessibility The financial reality of these treatments is something most comparison articles gloss over
Capsules and shots may involve different dosing, absorption, monitoring needs, and safety considerations
Don't skip your next dose or take corrective action
Preclinical study in mice with streptozotocin-induced diabetes that showed glucose-independent amelioration of kidney fibrosis with the DPP-4 inhibitor linagliptin